Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000243146 | SCV000311756 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000833471 | SCV000975234 | benign | not provided | 2018-06-14 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genome- |
RCV001789293 | SCV002031739 | benign | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 | 2021-10-25 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001789291 | SCV002031740 | benign | Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1 | 2021-10-25 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001789292 | SCV002031743 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2K | 2021-10-25 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003765532 | SCV004573789 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2K; Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1; Walker-Warburg congenital muscular dystrophy | 2023-04-23 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000833471 | SCV005324274 | benign | not provided | criteria provided, single submitter | not provided | ||
Clinical Genetics, |
RCV000243146 | SCV001917376 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000243146 | SCV001967261 | benign | not specified | no assertion criteria provided | clinical testing |